Celera (CRA) Reports Mixed Q2 Earnings
More News related to CRA
- Celera to Webcast Presentation at JPMorgan Healthcare Conference
- Celera (CRA) and Abbott (ABT) Revise Strategic Alliance
- Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
- Celera to Webcast Upcoming Financial Presentations
- Celera Elects Wayne I. Roe to Board of Directors
Celera (NYSE: CRA) reports a Q2 loss of $0.01, 1 cent lower than the analyst estimate of $0.00. Revenues for the quarter were $43.4 million, versus the consensus of $41.88 million.
Celera Corporation delivers personalized disease management products and services in the United States.
Related Categories
EarningsStocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
